An edition of Glaucoma
(2008)
Glaucoma
an open window to neurodegeneration and neuroprotection
by Carlo Nucci
- 0 Ratings
- 1 Want to read
- 0 Currently reading
- 0 Have read
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Previews available in: English
Showing 4 featured editions. View all 4 editions?
| Edition | Availability |
|---|---|
1
Glaucoma: a Pancitopatia of the Retina and Beyond
2020, Elsevier
in English
0128211075 9780128211076
|
zzzz
Libraries near you:
WorldCat
|
|
2
Glaucoma: a Pancitopatia of the Retina and Beyond
2020, Elsevier
in English
0128211067 9780128211069
|
zzzz
Libraries near you:
WorldCat
|
|
3
Glaucoma: an Open-Window to Neurodegeneration and Neuroprotection
2008, Elsevier Science & Technology Books
in English
0080932800 9780080932804
|
zzzz
Libraries near you:
WorldCat
|
4
Glaucoma: an open window to neurodegeneration and neuroprotection
2008, Elsevier
in English
0444532560 9780444532565
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Table of Contents
1.
Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects -- -- 2.
Predictive models to estimate the risk of glaucoma development and progression -- -- 3.
Intraocular pressure and central corneal thickness -- -- 4.
Angle-closure: risk factors, diagnosis and treatment -- -- 5.
Early diagnosis of glaucoma -- -- 6.
Monitoring glaucoma progression -- -- 7.
Standard automated perimetry and algorithms for monitoring glaucoma progression -- -- 8.
Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma -- -- 9.
Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma -- -- 10.
The role of OCT in glaucoma management -- -- 11.
Functional laser Doppler flowmetry of the optic nerve: physiological aspects and clinical applications -- -- 12.
Advances in neuroimaging of the visual pathways and their use in glaucoma -- -- 13.
Primary open angle glaucoma: an overview of medical therapy -- -- 14.
The treatment of normal-tension glaucoma -- -- 15.
The management of exfoliative glaucoma -- -- 16.
Laser therapies for glaucoma: new frontiers -- -- 17.
Modulation of wound healing during and after glaucoma surgery -- -- 18.
Surgical alternative to trabeculectomy -- -- 19
Modern aqueous shunt implantation: future challenges -- -- 20. Model systems for experimental studies: retinal ganglion cells in culture -- 21.
Rat models for glaucoma research -- -- 22.
Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection -- -- 23.
Clinical trials in neuroprotection.
24.
Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria -- -- 25.
Astrocytes in glaucomatous optic neuropathy -- -- 26.
Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation -- -- 27.
Oxidative stress and glaucoma: injury in the anterior segment of the eye -- -- 28
TNF-alpha signaling in glaucomatous neurodegeneration -- -- 29.
Involvement of the Bc12 gene family in the signaling and control of retinal ganglion cell death -- -- 30.
Assessment of neuroprotection in the retina with DARC -- -- 31.
Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection -- -- 32.
Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration -- -- 33.
Changes of central visual receptive fields on experimental glaucoma -- -- 34.
Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma --
Stem cells for neuroprotection in glaucoma -- -- 36.
The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells -- -- 37.
Evidence of the neuroprotective role of citicoline in glaucoma patients -- -- 38.
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon -- -- 39.
Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection -- -- 40.
17Beta-estradiol prevents retinal ganglion cell loss induced by the acute rise of intraocular pressure in rat.
Edition Notes
Includes bibliographical references and index.
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
| December 26, 2021 | Edited by ImportBot | import existing book |
| August 1, 2020 | Edited by ImportBot | import existing book |
| January 4, 2012 | Created by LC Bot | import new book |